RecruitingNCT07743567

Gestational Response, Outcomes, and Weight After GLP-1 Use


Sponsor

University of Kansas Medical Center

Enrollment

400 participants

Start Date

Apr 13, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to: * Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure. * Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure. Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences. Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria3

  • Adult women
  • Less than or equal to 20 weeks gestation at first visit
  • English speaking

Exclusion Criteria7

  • <18 years at time of initial visit
  • Type 2 diabetes
  • History of bariatric surgery
  • Multiple gestation
  • Cannot consent for themselves
  • Cannot read and speak English
  • Incarcerated

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Kansas Medical Center

Kansas City, Kansas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07743567


Related Trials